In various malignant entities, those Tregs present in the immune microenvironment of the tumor regularly express TIGIT on their cell surface [28,29,30], and it was shown that blockade of TIGIT leads to a significant decrease in Tregs [31,32]. This evidence concerns the gene TIGIT and neoplasm.